SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (9450)12/13/2002 9:37:14 PM
From: ewolf  Read Replies (1) of 9719
 
Notes on the meeting will be out on monday according to fda site. The outcome of this meeting is certainly unknowable, a total crapshoot. If the fda is satisfied with the recent safety data submitted by corixa and even the medical people can't figure out why the drug hasn't been approved, it almost seems logical to think approval. On the other hand, even with approval, the stock isn't likely to pop too much because it's going to take time for bex to gain usage. I guess this is the final answer for all of us who have thought bexaar is a good drug. good luck. eaw
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News